Global Health Stock

Global Health ROE

The Return on Equity (ROE) of Global Health (GLH.AX) as of Aug 5, 2026 is 23.20 %. In the previous year, Return on Equity (ROE) was 45.24 % — a change of -48.72% (lower).

ROE

23.20 %

YoY

-48.72%

Last updated:

In 2026, Global Health's return on equity (ROE) was 23.20 %, a -48.72% increase from the 45.24 % ROE in the previous year.

Access this data via the Eulerpool API

Global Health Stock analysis

What does Global Health do? Global Health Ltd is a British company that has been operating in the healthcare industry since 2004. Its foundation was a response to the increasing demand for better access to healthcare in developing countries. The company has continuously expanded and improved its business model to meet the changing demands of the healthcare industry. An important aspect of Global Health Ltd's business model is its collaboration with governments and non-governmental organizations (NGOs). The company provides comprehensive consultation services to assist governments in planning, developing, and implementing healthcare programs. This includes improving vaccination programs, strengthening healthcare systems, and developing strategies to reduce diseases. Through partnerships with NGOs, Global Health Ltd also enables access to healthcare services in rural and remote areas. The company also provides services in the field of medical research and development, working closely with academic institutions, non-profit organizations, and pharmaceutical companies to promote the development of new drugs and vaccines and support clinical research. Global Health Ltd offers specialized divisions focused on specific areas of the healthcare industry. For example, the company provides medical devices and equipment, including mobile healthcare solutions, to meet the increasing importance of digital technology in healthcare. Additionally, Global Health Ltd is involved in training and education for medical professionals, including training programs for healthcare personnel in developing countries and training for pharmaceutical companies and clinical research institutions. Another important division of the company is its healthcare services, operating healthcare centers in various countries, including clinics that offer specialized services such as ophthalmology, gynecology, and obstetrics. These healthcare centers aim to provide high-quality healthcare at affordable costs and serve as important sources of healthcare and prevention in many regions. Global Health Ltd also offers nutritional supplements specifically tailored to the needs of children and pregnant women. These products are developed and manufactured in collaboration with health authorities and NGOs in developing countries to combat malnutrition and deficiencies. Through its diverse offerings and collaborations with governments, NGOs, and other stakeholders, Global Health Ltd is committed to improving access to healthcare worldwide. The company strives to enable sustainable and affordable healthcare for all, making an important contribution to the global health agenda. Global Health is one of the most popular companies on Eulerpool.

ROE Details

Decoding Global Health's Return on Equity (ROE)

Global Health's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Global Health's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Global Health's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Global Health’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Global Health stock

Return on Equity (ROE) of Global Health is 23.20 % in 2026.

Return on Equity (ROE) of Global Health changed from 45.24 % to 23.20 %, representing a -48.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Global Health since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Global Health with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Global Health

All Key Metrics — Global Health